What are Acadia Pharmaceuticals's profit margins?

Gross margin is 91.5% and operating margin is 7.4%, with a 34.3% net margin.

Where does Acadia Pharmaceuticals's income statement data come from?

Every line is extracted from Acadia Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Acadia Pharmaceuticals ACAD Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$1.1B+2.2%	$1.07B+2.3%	$1.05B+2.8%	$1.02B+2.3%	$996.28M+4.0%
Total cost of revenue	$93.4M+4.9%	$89M+5.2%	$84.58M+3.4%	$81.79M+3.2%	$79.28M-3.1%
Gross profit	$1B+2.0%	$982.51M+2.1%	$962.54M+2.7%	$937.1M+2.2%	$917M+4.7%
Gross margin	91.5%-0.2pp	91.7%-0.2pp	91.9%-0.1pp	92%-0.1pp	92%+0.6pp
Research and development	$327.41M-0.4%	$328.8M-4.6%	$344.78M+6.6%	$323.55M+0.5%	$321.84M+6.1%
Selling, general and administrative	$593.54M+8.1%	$548.89M+4.9%	$523.36M0.0%	$523.25M+3.2%	$506.81M+3.8%
Total costs & expenses	$1.01B+4.9%	$966.69M+19.9%	$806.2M+3.1%	$782.08M+2.7%	$761.41M+4.7%
Operating income	$80.91M-22.8%	$104.81M-56.5%	$240.92M+1.7%	$236.81M+0.8%	$234.87M+1.8%
Operating margin	7.4%-2.4pp	9.8%-13.2pp	23%-0.2pp	23.2%-0.3pp	23.6%-0.5pp
Interest expense	$31.88M+0.5%	$31.72M+4.4%	$30.4M+5.8%	$28.74M+3.2%	$27.85M+9.4%
Other income (expense), net	$2.33M-1.9%	$2.37M+0.9%	$2.35M+0.7%	$2.33M+9.8%	$2.13M+16.6%
Income before income taxes	$115.11M-17.1%	$138.9M-49.2%	$273.67M+2.2%	$267.88M+1.1%	$264.85M+2.6%
Income tax expense	-$260.54M-3.4%	-$252.1M-2,117%	$12.5M-72.7%	$45.72M+27.1%	$35.97M+13.7%
Net income	$375.65M-3.9%	$391M+49.7%	$261.17M+17.6%	$222.16M-2.9%	$228.88M+1.1%
Net margin	34.3%-2.2pp	36.5%+11.5pp	24.9%+3.1pp	21.8%-1.2pp	23%-0.7pp
Diluted earnings per share	$2.21-3.9%	$2.30+48.4%	$1.55+16.5%	$1.33-2.9%	$1.37+0.7%
EBITDA	$92.71M-20.5%	$116.57M-54.3%	$254.97M+1.8%	$250.48M+0.9%	$248.18M+0.6%
EBITDA margin	8.5%-2.4pp	10.9%-13.5pp	24.3%-0.2pp	24.6%-0.3pp	24.9%-0.8pp
EBIT	$80.91M-22.8%	$104.81M-56.5%	$240.92M+1.7%	$236.81M+0.8%	$234.87M+1.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Acadia Pharmaceuticals's profit margins?: Gross margin is 91.5% and operating margin is 7.4%, with a 34.3% net margin.
Where does Acadia Pharmaceuticals's income statement data come from?: Every line is extracted from Acadia Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.